Simon Amies

Partner
samies@cooley.com
Full contact info

About Simon

Simon is a partner in Cooley’s life sciences practice advising on mergers & acquisitions (public and private), initial public offerings and other capital-raising transactions, and venture and growth capital investments. Simon has extensive experience in advising companies at all stages of their development, as well as counseling investors and investment banks. He has represented a wide range of clients in the life sciences, technology and sustainable technology industries.

View full bio

Experience

Ochre Bio Announces Partnership With Boehringer Ingelheim

Ochre Bio Announces Partnership With Boehringer Ingelheim

April 22, 2024

Cooley advised Ochre Bio, a UK-based pioneer in chronic liver disease medicine development with labs in New York and Taipei, on its partnership with Boehringer Ingelheim focused on the discovery and development of novel, first-in-class regenerative treatments for chronic liver diseases, such as late-stage metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis.

Read more

Related contacts

Alan W. Tamarelli
Partner, New York
Simon Amies
Partner, London
Aaron Pomeroy
Partner, Colorado
Frances Stocks Allen
Partner, London
Jiqiang Lin
Associate, New York
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

Healthcare
Life Sciences
Life Sciences Corporate Partnering and Licensing
Emerging Companies
Tax

Admissions and credentials

England and Wales

Rankings and accolades

The Legal 500 UK: Venture Capital (2021 – 2022)

The Legal 500 UK: M&A: Upper Mid-Market and Premium Deals (2021 – 2022)

The Legal 500 UK: Equity Capital Markets: Small and Mid-Cap (2021 – 2022)

International Financial Law Review (IFLR) Europe Awards 2015, shortlisted for Deals of the Year: Equity